Aclaris Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:ACRS) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 220.33 M198.09 M189.15 M175.53 M160.46 M 負債合計 64.77 M54.03 M57.41 M55.43 M57.38 M 純資産合計 155.55 M144.07 M131.74 M120.1 M103.08 M 負債および純資産合計 220.33 M198.09 M189.15 M175.53 M160.46 M 有利子負債合計 ————— 純負債 —————

ニュース

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

H.C. WainwrightがAclaris TherapeuticsのBuy評価を継続

Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright

Stifelがパイプラインを評価しAclaris Therapeuticsの目標株価を3ドルに引き上げ

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

【決算速報】アクラリス・セラピューティクス、売上高は予想を下回り、利益は予想を下回る結果に

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris、喘息患者を対象としたATI-052の第1b相試験を開始

Aclaris starts phase 1b trial of ATI-052 in asthma patients